These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 23822637
1. Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles. Wu S, Sun K, Wang X, Wang D, Wan X, Zhang J. J Agric Food Chem; 2013 Jul 31; 61(30):7268-75. PubMed ID: 23822637 [Abstract] [Full Text] [Related]
2. Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells. Li Z, Ha J, Zou T, Gu L. Food Funct; 2014 Jun 31; 5(6):1278-85. PubMed ID: 24741679 [Abstract] [Full Text] [Related]
3. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. Wang D, Taylor EW, Wang Y, Wan X, Zhang J. Int J Nanomedicine; 2012 Jun 31; 7():1711-21. PubMed ID: 22619522 [Abstract] [Full Text] [Related]
4. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid. Hong Z, Xu Y, Yin JF, Jin J, Jiang Y, Du Q. J Agric Food Chem; 2014 Dec 31; 62(52):12603-9. PubMed ID: 25483592 [Abstract] [Full Text] [Related]
5. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity. Zhang J, Zhou X, Yu Q, Yang L, Sun D, Zhou Y, Liu J. ACS Appl Mater Interfaces; 2014 Jun 11; 6(11):8475-87. PubMed ID: 24758520 [Abstract] [Full Text] [Related]
6. Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles. Li B, Du W, Jin J, Du Q. J Agric Food Chem; 2012 Apr 04; 60(13):3477-84. PubMed ID: 22409289 [Abstract] [Full Text] [Related]
7. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Dube A, Nicolazzo JA, Larson I. Eur J Pharm Sci; 2011 Oct 09; 44(3):422-6. PubMed ID: 21925598 [Abstract] [Full Text] [Related]
8. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Hu B, Ting Y, Yang X, Tang W, Zeng X, Huang Q. Chem Commun (Camb); 2012 Feb 28; 48(18):2421-3. PubMed ID: 22266839 [Abstract] [Full Text] [Related]
9. Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells. Li Z, Gu L. J Agric Food Chem; 2014 Feb 12; 62(6):1301-9. PubMed ID: 24446922 [Abstract] [Full Text] [Related]
10. [Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles]. Zu YG, Yuan S, Zhao XH, Zhang Y, Zhang XN, Jiang R. Yao Xue Xue Bao; 2009 May 12; 44(5):525-31. PubMed ID: 19618731 [Abstract] [Full Text] [Related]
11. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles. Liu F, Majeed H, Antoniou J, Li Y, Ma Y, Yokoyama W, Ma J, Zhong F. Carbohydr Polym; 2016 Sep 20; 149():340-7. PubMed ID: 27261758 [Abstract] [Full Text] [Related]
12. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. Lambert JD, Kim DH, Zheng R, Yang CS. J Pharm Pharmacol; 2006 May 20; 58(5):599-604. PubMed ID: 16640828 [Abstract] [Full Text] [Related]
13. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Shin SC, Choi JS. Anticancer Drugs; 2009 Aug 20; 20(7):584-8. PubMed ID: 19491656 [Abstract] [Full Text] [Related]
14. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate. Dube A, Nicolazzo JA, Larson I. Eur J Pharm Sci; 2010 Oct 09; 41(2):219-25. PubMed ID: 20600878 [Abstract] [Full Text] [Related]
15. Native and thermally modified protein-polyphenol coassemblies: lactoferrin-based nanoparticles and submicrometer particles as protective vehicles for (-)-epigallocatechin-3-gallate. Yang W, Xu C, Liu F, Yuan F, Gao Y. J Agric Food Chem; 2014 Nov 05; 62(44):10816-27. PubMed ID: 25310084 [Abstract] [Full Text] [Related]
16. Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate. Hu B, Ting Y, Zeng X, Huang Q. J Agric Food Chem; 2013 Jan 30; 61(4):875-81. PubMed ID: 23293838 [Abstract] [Full Text] [Related]
17. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. Krupkova O, Ferguson SJ, Wuertz-Kozak K. J Nutr Biochem; 2016 Nov 30; 37():1-12. PubMed ID: 27770867 [Abstract] [Full Text] [Related]
18. Effect of processing on physicochemical characteristics and bioefficacy of β-lactoglobulin-epigallocatechin-3-gallate complexes. Lestringant P, Guri A, Gülseren I, Relkin P, Corredig M. J Agric Food Chem; 2014 Aug 20; 62(33):8357-64. PubMed ID: 25077960 [Abstract] [Full Text] [Related]
19. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Yang QQ, Wei XL, Fang YP, Gan RY, Wang M, Ge YY, Zhang D, Cheng LZ, Corke H. Crit Rev Food Sci Nutr; 2020 Aug 20; 60(8):1243-1264. PubMed ID: 30799648 [Abstract] [Full Text] [Related]
20. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Cancer Epidemiol Biomarkers Prev; 2001 Jan 20; 10(1):53-8. PubMed ID: 11205489 [Abstract] [Full Text] [Related] Page: [Next] [New Search]